Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study-Reference-Cited by-同舟云学术

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

Published:2020-07-02 Issue:1 Volume:136 Page:144-147
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Tremblay Douglas¹^ORCID,van Gerwen Maaike²³^ORCID,Alsen Mathilda²,Thibaud Santiago¹^ORCID,Kessler Alaina¹^ORCID,Venugopal Sangeetha¹,Makki Iman¹^ORCID,Qin Qian¹^ORCID,Dharmapuri Sirish¹^ORCID,Jun Tomi¹^ORCID,Bhalla Sheena¹,Berwick Shana¹,Feld Jonathan¹,Mascarenhas John¹^ORCID,Troy Kevin¹,Cromwell Caroline¹,Dunn Andrew⁴,Oh William K.¹^ORCID,Naymagon Leonard¹^ORCID

Affiliation:

1. Division of Hematology and Medical Oncology, Tisch Cancer Institute,

2. Department of Otolaryngology-Head and Neck Surgery,

3. Institute for Translational Epidemiology, and

4. Division of Hospital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

Abstract

Tremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy. After matching for existing comorbidities, this retrospective observational study finds no evidence for an effect of prediagnosis anticoagulation on mortality.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/136/1/144/1747537/bloodbld2020006941.pdf

Reference20 articles.

1. WHO declares COVID-19 a pandemic;Cucinotta;Acta Biomed,2020

2. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention;Wu;JAMA,2020

3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost,2020

4. ISTH interim guidance on recognition and management of coagulopathy in COVID-19;Thachil;J Thromb Haemost,2020

5. COVID-19 and its implications for thrombosis and anticoagulation;Connors;Blood,2020

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial;Thrombosis Research;2024-11

2. Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis;World Journal of Methodology;2024-09-20

3. Impact of prior oral anticoagulation therapies on post‐discharge outcomes after COVID‐19: Results from a global federated health network analysis;European Journal of Clinical Investigation;2024-08-06

4. Impacto del uso previo de antiagregantes plaquetarios en la susceptibilidad, la progresión y la gravedad de la COVID-19: un estudio poblacional;Revista Española de Cardiología;2024-07

5. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study;Revista Española de Cardiología (English Edition);2024-07